Aug 20, 2021 CloudMD Software & Services Inc.

CloudMD to Report Second Quarter Financial Results on August 25, 2021

VANCOUVER, British Columbia, Aug. 20, 2021 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV:DOC)(OTCQB:DOCRF)(Frankfurt: 6PH)(the “Company” or “CloudMD”), a healthcare technology company revolutionizing the delivery of care, announces that it will report its second-quarter 2021 financial results on Wednesday, August 25, 2021, after market close. Related earnings release materials can be found in the Investors section on CloudMD’s website.

Management will be hosting an earnings conference call and webinar on the same day (Wednesday, August 25, 2021, at 2:00 pm Pacific Time / 5:00 pm Eastern Time) to review and discuss the quarterly operational highlights and financial results, followed by a question and answer period. Questions can be asked through the dial-in numbers only.

Conference call details:

Toll-Free Dial-In Number: (833) 562-0117
International Dial-In Number: (661) 567-1009
Conference ID: 6446418

Webcast Link: https://edge.media-server.com/mmc/p/o2cjg6ix

About CloudMD Software & Services

CloudMD Software & Services Inc. (TSXV:DOC)(OTCQB:DOCRF)(Frankfurt: 6PH) is digitizing the delivery of healthcare by providing a patient-centric approach, with an emphasis on continuity of care. By leveraging healthcare technology, the Company is building one, connected platform that addresses all points of a patient’s healthcare journey and provides better access to care and improved outcomes. Through CloudMD’s proprietary technology, the Company delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, educational resources, and artificial intelligence (AI).

CloudMD currently services a combined ecosystem of over 7,000 psychiatrists, approximately 4,500 therapists and counselors, approximately 4,000 psychologists, over 22,000 family physicians, over 34,000 medical specialists, over 1,500 allied health professionals, over 500 clinics, and over 5 million individuals across North America. CloudMD’s Enterprise Health Solutions Division includes one of the top 4 Employee Assistance Programs in Canada and offers a comprehensive, digitally connected platform for corporations, insurers, and advisors to better manage the health and wellness of their employees and customers. For more information visit: https://investors.cloudmd.ca.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Please See Disclaimer

STOCKS YOU MAY LIKE

CloudMD-PR

CloudMD to Acquire Rxi Group of Companies, an Established One-Stop Patient Support Logistics Company and Leading Customer Relationship Management Technology Provider

Jan 26, 2021 CloudMD Software & Services Inc.
Adds $16.6 million in revenue and increases CloudMD’s current annualized run-rate to over $60 million Rxi’s pharmaceutical logistic services include drug distribution, patient navigation assistance, a preferred network of over 500 pharmacies and real-time universal ... [Read]

Disclosure:

1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector.

2) The Article was issued on behalf of and sponsored by CloudMD Software & Services Inc. Market Jar Media Inc. expects to receive from CloudMD Software & Services Inc.’s Digital Marketing Agency of Record (Native Ads Inc.) one hundred eighty nine thousand CAD Dollars for 32 campaign days (23 business days).

3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on Microsmallcap.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on Microsmallcap.com.

5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.